SCHEMBL6193699

SCHEMBL6193699

CCCc1c(N2CCCC2=O)csc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ USP2 O75604 1/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ PKM P14618 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ NMT1 P30419 1/20 0.32
▸ RARA P10276 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6193694 0.80 ALDH1A1 (0.40) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL16058121 0.77 ALDH1A1 (0.40) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL16403235 0.75 ALDH1A1 (0.41) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL16058346 0.74 ALDH1A1 (0.46) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL5186125 0.69 HSD17B10 (0.40) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5221777 0.68 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL3187893 0.68 LMNA (0.39) ALDH1A1CYP1A2CYP2C9HPGDUSP2
SCHEMBL16403233 0.67 ALDH1A1 (0.40) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL16058120 0.67 ALDH1A1 (0.40) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL16057603 0.66 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3021879-A2 METHODS, SYSTEMS, AND COMPOSITIONS FOR PROMOTING BONE GROWTH Cayman Chemical Company, Incorporated (US) 2016-05-25 — — EP disclosed
EP-2989098-A2 LACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND CONDITIONS Cayman Chemical Company, Incorporated (US) 2016-03-02 — — EP disclosed
WO-2015009991-A2 METHODS, SYSTEMS, AND COMPOSITIONS FOR PROMOTING BONE GROWTH CAYMAN CHEMICAL COMPANY, INC. (US) 2015-01-22 — — WO disclosed
WO-2014144584-A2 LACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND CONDITIONS CAYMAN CHEMICAL COMPANY, INC. (US) 2014-09-18 — — WO disclosed
EP-1558602-A2 2-PYRROLIDONES AS EP4 RECEPTOR AGONISTS MERCK FROSST CANADA INC. (CA) 2005-08-03 — — EP disclosed
WO-2004037786-A2 2-PYRROLIDONES AS EP4 RECEPTOR AGONISTS MERCK FROSST CANADA & CO. (CA) 2004-05-06 — — WO disclosed
Send feedback